ReviewClinical colorectal cancer2022

The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer.

Alisha Bent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.